Literature DB >> 22669878

Atypical toxoplasmic retinochoroiditis.

Sofia Theodoropoulou1, Conrad Schmoll, Kate Templeton, Baljean Dhillon.   

Abstract

We report a case of re-activation of Toxoplasma gondii as a cause of atypical retinal necrosis in an immunocompetent individual. The rapid development of necrotising confluent retinochoroiditis and vitreous inflammation necessitated urgent aqueous humor PCR analysis, which was positive for T gondii. The patient was treated with two intravitreal injections of clindamycin, along with oral sulphadiazine, pyrimethamine, folinic acid and prednisolone. He developed central retinal arterial occlusion, as a complication of toxoplasmic retinochoroiditis, and immediate anterior chamber paracentesis was performed with visual recovery. The injection of intravitreal clindamycin with concomitant oral therapy was associated with control of toxoplasmic retinochoroiditis and resolution of vitreous inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22669878      PMCID: PMC4543018          DOI: 10.1136/bcr.12.2011.5419

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Necrotising retinopathies simulating acute retinal necrosis syndrome.

Authors:  B Balansard; B Bodaghi; N Cassoux; C Fardeau; S Romand; F Rozenberg; N A Rao; P Lehoang
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  Retinal vascular occlusions complicating acute toxoplasmic retinochoroiditis.

Authors:  R C Gentile; D M Berinstein; R Oppenheim; J B Walsh
Journal:  Can J Ophthalmol       Date:  1997-08       Impact factor: 1.882

3.  Branch retinal artery occlusion associated with recurrent toxoplasmic retinochoroiditis.

Authors:  C M Morgan; E S Gragoudas
Journal:  Arch Ophthalmol       Date:  1987-01

4.  Branch artery obstruction caused by acute toxoplasmosis.

Authors:  R A Braunstein; J D Gass
Journal:  Arch Ophthalmol       Date:  1980-03

5.  Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis.

Authors:  Masoud Soheilian; Alireza Ramezani; Ahmad Azimzadeh; Mohammad Mehdi Sadoughi; Mohammad H Dehghan; Reza Shahghadami; Mehdi Yaseri; Gholam A Peyman
Journal:  Ophthalmology       Date:  2010-08-12       Impact factor: 12.079

6.  Branch retinal arterial occlusion associated with toxoplasmic chorioretinitis.

Authors:  Cem Küçükerdönmez; Gürsel Yilmaz; Yonca A Akova
Journal:  Ocul Immunol Inflamm       Date:  2004-09       Impact factor: 3.070

7.  Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features.

Authors:  Christine Fardeau; Stéphane Romand; Narsing A Rao; Nathalie Cassoux; Olivier Bettembourg; Philippe Thulliez; Phuc Lehoang
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

8.  Intravitreal clindamycin for toxoplasmic retinochoroiditis.

Authors:  Lucia Sobrin; Leila I Kump; C Stephen Foster
Journal:  Retina       Date:  2007-09       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.